Canadian ETFs: A look at December’s launches and terminations - and how the industry grew in 2020 Contributed to The Globe and Mail Published January 14, 2021 Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account
Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer
The Canadian ETF industry reached $257 billion in assets under management at the end of November, compared to $205 billion one year ago, for an annual growth rate of 25.4%. ETFs reported record inflows of $40 billion this year representing 19.5% of the AUM at the beginning of the year. In the last 5-year period, the ETF industry passed from $89.6 billion to $257 billion for an annual growth rate of 23.5%.
VMware, Pat Gelsinger, effective Feb. 15. Since Swan took over in 2019, Intel has divested from non-core assets while making acquisitions that
strengthened its core business. But as
Barron’s notes, “Swan doesn’t have semiconductors in his DNA and is known as more of a software and finance executive than a man with deep technical expertise.” Gelsinger, on the other hand, is
a prominent technical expert in the chip industry. He’s a trained engineer who has written a microprocessor programming book, holds several patents, helped create Wi-Fi technology and spent three decades at Intel earlier in his career. “After careful consideration, the board concluded that now is the right time to make this leadership change to draw on Pat’s technology and engineering expertise during this critical period of transformation at Intel,” Intel chairman Omar Ishrak said in a statement.
Dreamstime
Biotech companies have been riding the wave of Covid-19 vaccine excitement for months now, as the pandemic reignited investors’ confidence in the value of their research, technology, and platforms.
Leaders in coronavirus vaccine development like
Moderna (ticker: MRNA) and
Novavax (NVAX) have seen their stocks surge wildly, but the rally isn’t limited to them. The biggest winners in 2020 also included firms with breakthroughs in other areas, such as
Twist Bioscience (TWST), which developed a DNA synthesis platform that made Covid testing possible, and
Investing in biotech isn’t easy, however. It’s a risky space where companies often have no income-generating products, and the drugs in development have no guarantee of government approval. Investors are often attracted by biotech stocks’ potential for outsize gains, but these companies can also bring sudden, steep declines if their high-stake efforts fail in clinical tr
Cathie Wood, CEO of ARK Investment Management. Alex Flynn/Bloomberg
Star fund manager Cathie Wood is setting her eyes on yet another booming industry, and it’s setting the stocks on fire.
ARK Investment Management, an asset-management firm led by Wood, filed late Wednesday to launch the ARK Space Exploration exchange-traded fund under the ticker ARKX.
Although the fund isn’t on the market yet and its exact holdings are unknown, the news itself was bullish enough to spark a rally in many companies related to the space business.
It’s the latest demonstration of how popular and influential ARK Investment and its founder Wood has become in the past year.
Order Reprints Print Article
Space is cold, but space investing is heating up. Space-linked stocks are rocketing higher Wednesday because a well-known Tesla bull has turned her gaze upward.
ARK Invest, founded by technology disruption guru Cathie Wood, is planning a new exchange-traded fund focused on space stocks, based on filings with the Securities and Exchange Commission.
Wood,.
Close
Space is cold, but space investing is heating up.
From